The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEveryman Media Regulatory News (EMAN)

Share Price Information for Everyman Media (EMAN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 57.50
Bid: 57.00
Ask: 58.00
Change: 0.00 (0.00%)
Spread: 1.00 (1.754%)
Open: 57.50
High: 57.50
Low: 57.50
Prev. Close: 57.50
EMAN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update and Notice of Results

18 Aug 2023 07:00

RNS Number : 7056J
Everyman Media Group PLC
18 August 2023
 

18 August 2023

 

Everyman Media Group PLC

("Everyman" the "Company" or the "Group")

Trading Update and Notice of Results

Everyman Media Group PLC (AIM: EMAN) provides the following trading update for the 26 weeks ending 29 June 2023.

Trading continues to be in line with expectations and the Board remains confident that the financial performance of the Company for the full year ending 28 December 2023 will be in line with market expectations1. Everyman continues to grow both operationally and financially and remains an affordable and popular choice for consumers.

Key highlights

· Group Revenue of £38.3m (2022: £40.7m) against a strong H1 2022 comparator. The majority of key 2023 releases fall in H2 2023, leading to a second half weighting to annual financial performance.

· Group EBITDA of £5.8m (2022: £7.5m), with the prior period benefitting from the reduced rate of VAT in the first quarter of last year worth £0.9m in EBITDA, and popular film releases.

· Three new venues opened at the end of H1, taking the Group estate to a total of 41 venues.

Post period and outlook

· Barbie and Oppenheimer released in the final week of July, delivered record admissions and enabled the Group to achieve an exceptional month of trading:

 

Group Revenue of £10.6m (July 2022: £7.1m)

Group EBITDA of £2.6m (July 2022: £1.3m)

 

Looking forward, the H2 dominant film slate for 2023 has already seen the early success of Barbie and Oppenheimer at the Box Office, with the positive impact of both titles continuing into August. There is a strong pipeline of further titles set to be released including Dune: Part Two, Wonka, The Hunger Games: The Ballad of Songbirds & Snakes, Napoleon, and Killers of the Flower Moon.

The Group now operates 41 cinemas, having opened three new, promising venues in the period: a four-screen venue in Northallerton in May 2023, a three-screen venue in Plymouth and a four-screen venue in Salisbury in June 2023. The Group expects to open a new two-screen venue in Marlow in October 2023 and the pipeline for 2024 remains well-developed.

The Group intends to publish its interim results for the 26 weeks ended 29 June 2023 on Wednesday 27th September 2023.

Alex Scrimgeour, Chief Executive Officer of Everyman Media Group Plc, said:

"Everyman remains an affordable and popular choice for consumers. The record week of admissions we saw in July demonstrates both the value of original content, and the fact that cinema remains as relevant as ever. Alongside this, we continue to see increasing demand for our high-quality food and beverage offering. The all-encompassing Everyman experience leaves us very well placed to satisfy consumer demand for premium entertainment.

None of what we do would be possible without the incredible Everyman team both in our venues and head office. I would like to take this opportunity to thank them all for their hard work and willingness to go that extra mile for our customers. We have added three carefully selected new venues to our estate and we look forward to building on the significant momentum we have seen in July and August."

1 Current market forecasts for the year ended 28 December 2023 are revenue of £94.4m and Adjusted EBITDA of £17.2m.

 

For further information, please contact:

 

Everyman Media Group PLC

Tel: +44 (0)20 3145 0500

Alex Scrimgeour, Chief Executive

Will Worsdell, Finance Director

Canaccord Genuity Limited - (Nominated Adviser and Broker)

Tel: +44 (0)20 7523 8000

Bobbie Hilliam

Harry Pardoe

Alma (Financial PR Advisor)

Tel:  +44 (0)20 3405 0205

Rebecca Sanders-HewettDavid Ison

Joe Pederzolli

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFLATIIDLIV
Date   Source Headline
18th Apr 20249:17 amRNSDirector/PDMR Shareholding
17th Apr 20247:00 amRNSGrant of Options
16th Apr 20247:00 amRNSFinal Results to 28 December 2023
28th Mar 20247:00 amRNSNotice of Results and Investor Presentation
9th Feb 202412:45 pmRNSCorrection: Director/PDMR Shareholding
2nd Feb 20247:00 amRNSHolding(s) in Company
1st Feb 20247:00 amRNSDirector/PDMR Shareholding
31st Jan 20247:00 amRNSDirector/PDMR Shareholding
23rd Jan 20247:00 amRNSTrading Update
15th Dec 20237:00 amRNSAcquisition
23rd Nov 202311:19 amRNSDirector/PDMR Shareholding
22nd Nov 20231:36 pmRNSDirector/PDMR Shareholding
20th Oct 20237:00 amRNSDirector/PDMR Shareholding
3rd Oct 20237:00 amRNSDirector/PDMR Shareholding
2nd Oct 20237:00 amRNSDirector/PDMR Shareholding
27th Sep 20237:00 amRNSInterim Results
18th Aug 20232:20 pmRNSDirector/PDMR Shareholding
18th Aug 202312:00 pmRNSGrant of Options and Changes to Option Terms
18th Aug 20237:01 amRNSNew banking facilities
18th Aug 20237:00 amRNSTrading Update and Notice of Results
15th Jun 20234:41 pmRNSResults of Annual General Meeting
10th May 20231:30 pmRNSHolding(s) in Company
5th May 20231:45 pmRNSHolding(s) in Company
4th May 20237:00 amRNSPosting of Annual Report and Notice of AGM
12th Apr 20237:00 amRNSFinal Results to 29 December 2022
24th Mar 20237:00 amRNSNotice of Results
1st Feb 20235:11 pmRNSGrant of Options
25th Jan 20234:56 pmRNSDirector/PDMR Shareholding
23rd Jan 20239:00 amRNSDirector/PDMR Shareholding
23rd Jan 20237:00 amRNSTrading Update
8th Dec 20227:39 amRNSHolding(s) in Company
18th Nov 20227:00 amRNSDirectorate Change
25th Oct 20227:00 amRNSGrant of Options
28th Sep 20227:00 amRNSInterim Results
20th Sep 20227:00 amRNSDirector Appointment
11th Aug 20227:00 amRNSDirector/PDMR Shareholding
9th Aug 20227:00 amRNSDirector/PDMR Shareholding
29th Jul 20227:00 amRNSDirector/PDMR Shareholding
29th Jul 20227:00 amRNSHolding(s) in Company
27th Jul 20227:00 amRNSTrading Update
7th Jul 20227:00 amRNSDirector/PDMR Shareholding
28th Jun 20227:01 amRNSDirectorate Change
28th Jun 20227:00 amRNSDirectorate Change
17th Jun 20227:00 amRNSDirector/PDMR Shareholding
16th May 20225:30 pmRNSPosting of Annual Report and Notice of AGM
31st Mar 20227:00 amRNSDirectorate Change
25th Mar 20227:00 amRNSFinal Results to 30 December 2021
31st Jan 20228:31 amRNSTotal Voting Rights
21st Jan 20227:00 amRNSTrading Update
20th Jan 20225:15 pmRNSExercise of Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.